5 mins

• Welcome & antitrust notice
• Introduction of new members
• Agenda review
• Recording with transcription is now automatic

Chairs

Antitrust Policy Notice: Attendees are reminded to adhere to the meeting agenda and not participate in activities prohibited under antitrust and competition laws.

ToIP Policy: Only members of ToIP who have signed the necessary agreements are permitted to participate in this activity beyond an observer role.

ToIP AIMWG IPR Policy: see WG wiki

5 mins

• Introduction of new members
• Any general announcements news that could be of interest to the WG
• To review of action items that are not in the agenda below

All

• Any new members to introduce
• Quick follow up of open action items (see below)

• News to share

• Recap last week’s call/action items

5 mins

Schedule for next few weeks

For the next few weeks:

• May 21: @Eric Drury

• May 28: Continue on #Duties. @Steve Vitka

• June 4: I am back - #TEA Spec

45 mins

Standing Topic Series: #TEA

@Wenjing Chu

• Continue on TEA draft spec discussions

0 mins

Other 2026 Priorities (still open for leads to substantiate these topics)

Initiative Leads

• Continue to refine/organize other priorities in this 2026 spreadsheet: https://docs.google.com/spreadsheets/d/1GorGyPHWGJ5T00WnmLZ8bHGUF0dhCGn5MxwyJsxrb5s/edit?gid=0#gid=0

• https://docs.google.com/document/d/1pGNXH-mXS1P9FwfdIlHB39_gksN29tc7nCsTofp797w/edit?tab=t.0#heading=h.o1cpti7hxeah

• Task force idea on accountability, Fiduciary duty → standing thread in the current meeting starting next week.

0 mins

Action Items to Follow Up

All

• AIMWG in Google Drive is still under Tech Stack WFG - needed to elevate AIM to WG level
• Move from Confluence to GitHub - Why? What does it take? How? On Why: it will make AI agent use a lot easier.

• Topic 3: Disclosure, retention, re-purpose of personal data. Let’s discuss these privacy related features and see how the current proposed architecture would support.

• Others ------- if we have more time

• Topic 2: SOUL.md, AGENT.md, CLAUDE.md, and discussion thread on informal data

• Topic 4: How TEA relates to DTG, MCP-I, VerifEye, MCP, A2A, … maybe compile into a FAQ

• Other priorities - dormant now but we don’t want to lose them

•